Estabrook Capital Management Bristol Myers Squibb CO Transaction History

Estabrook Capital Management

$650 Billion
Q2 2024

A detailed history of Estabrook Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Estabrook Capital Management holds 12,345 shares of BMY stock, worth $656,630. This represents 0.08% of its overall portfolio holdings.

Number of Shares

12,345

Previous 12,395 0.4%

Holding current value

$656,630

Previous $672 Million 23.73%

% of portfolio

0.08%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $2,012 - $2,649	-50 Reduced 0.4%	12,345 $513 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $153,536 - $174,080	-3,200 Reduced 20.52%	12,395 $672 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $2,520 - $3,008	-52 Reduced 0.33%	15,595 $800 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $25,484 - $28,295	-400 Reduced 2.49%	15,647 $1 Billion
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $19,516 - $23,110	-285 Reduced 1.75%	16,047 $1.15 Billion
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $52 - $30,736	-400 Reduced 2.39%	16,332 $1.16 Billion
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $6,535 - $7,198	-90 Reduced 0.54%	16,732 $1.29 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $15,861 - $19,019	-258 Reduced 1.51%	16,822 $1.23 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $47,336 - $55,448	-800 Reduced 4.47%	17,080 $1.01 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $9,286 - $10,113	-150 Reduced 0.83%	17,880 $1.19 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $8,901 - $10,011	-150 Reduced 0.83%	18,030 $1.14 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $93,194 - $108,953	-1,700 Reduced 8.55%	18,180 $1.07 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $14,763 - $19,257	300 Added 1.53%	19,880 $1.28 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $27,072 - $32,280	-600 Reduced 2.97%	19,580 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $232,585 - $301,607	-4,770 Reduced 19.12%	20,180 $1.05 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $70,643 - $79,680	-1,280 Reduced 4.88%	24,950 $0
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $141,484 - $176,344	2,800 Added 11.95%	26,230 $0
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $14,980 - $17,245	-250 Reduced 1.06%	23,430 $0
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $1.31 Million - $1.51 Million	23,680	23,680 $0

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Estabrook Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Estabrook Capital Management with notifications on news.

Account

Estabrook Capital Management Bristol Myers Squibb CO Transaction History